That's the crazy thing. They are US approved. Their first 510K FDA approval was in 2006! Brilliant science, terrible past financial management. Went too fast on expanding global sales and burnt through the cash big time:
That was back in 2022/3. They had a massive salesforce globally that did not perform and took its toll on cash flows and in time the balance sheet and the share price crashed accordingly and killed by raises/corp action.
People should NOT look at third part share pricing charts, but rather the mkt cap history.
They are now onboard with Zimmer Biomet and were a binary call option investment....until now. This announcement greatly ups the odds of the company finally reaching critical mass on sales to repair its balance sheet. For a while it was looking like it might not. The all too often boom or bust story of bio-tech.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)